Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,726–1,750 of 27,380 studies, newest first · page 70 of 1096.

February 2026 25

  1. 2026-02-10

    Centiloids in Amyloid PET: A Practical Guide to Quantitation Interpretation

    ✓ Peer-reviewed Biomarkers Journal of Nuclear Medicine Technology

    Key finding: Although visual interpretation remains the clinical standard for amyloid PET, it may be limited in borderline cases and when assessing subtle changes in amyloid burden over time. +4 more findings

  2. 2026-02-10

    Effects of peer support interventions for family caregivers of persons with dementia: A systematic review and meta-analysis

    ✓ Peer-reviewed Caregiving Archives of gerontology and geriatrics

    Key finding: Peer support interventions suggest beneficial short-term effects on specific caregiver outcomes but lack long-term sustainability. +2 more findings

  3. 2026-02-10

    Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial

    ✓ Peer-reviewed Clinical trials JAMA

    Key finding: Of the 120 participants (mean age, 71.4 [SD, 8.6] years; 55% were female), 93 (77.5%) completed the trial.

  4. 2026-02-09

    Concurrent Gabapentin and Dihydropyridine Calcium Channel Blocker Use and Risk of Incident Dementia: An Active-Comparator Cohort Study

    ⚠ Preprint — not yet peer-reviewed Costs and economics medRxiv

    Key finding: Both classes act on neuronal calcium signaling, raising the question of whether their combined use is associated with greater cognitive risk than gabapentin alone. +4 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-02-09

    Disaggregating Poverty Estimates to Sub-County Level using Small Area Model: Application of EBP

    ✓ Peer-reviewed Risk factors International Journal of Poverty, Investment and Development

    Key finding: The results demonstrate similar poverty patterns as per county data findings on Kenya poverty report, 2022. +4 more findings

  6. 2026-02-09

    Social determinants of brain structure and cognition

    ✓ Peer-reviewed Risk factors Social science & medicine (1982)

    Key finding: We investigated whether neighborhood disadvantage, measured by the Area Deprivation Index (ADI), was associated with cognitive performance in older adults and patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD), and whether structural brain differences explained this relationship. +4 more findings

  7. 2026-02-09

    Additional file 1 of Factors influencing readiness for advance care planning in dementia: a qualitative interview study

    ✓ Peer-reviewed End-of-life care Figshare

    Key finding: Interview guides on experiences with advance care planning, factors influencing readiness for advance care planning, and the use of conversation aids among people with dementia, family caregivers, and healthcare professionals. +1 more finding

  8. 2026-02-09

    Additional file 1 of Factors influencing readiness for advance care planning in dementia: a qualitative interview study

    ✓ Peer-reviewed End-of-life care Figshare

    Key finding: Interview guides on experiences with advance care planning, factors influencing readiness for advance care planning, and the use of conversation aids among people with dementia, family caregivers, and healthcare professionals. +1 more finding

  9. 2026-02-09

    Additional file 2 of Factors influencing readiness for advance care planning in dementia: a qualitative interview study

    ✓ Peer-reviewed End-of-life care Figshare

    Key finding: Coding tree of main categories and specific sub categories describing factors influencing readiness for advance care planning among people with dementia, family caregivers, and healthcare professionals. +1 more finding

  10. 2026-02-09

    Additional file 2 of Factors influencing readiness for advance care planning in dementia: a qualitative interview study

    ✓ Peer-reviewed End-of-life care Figshare

    Key finding: Coding tree of main categories and specific sub categories describing factors influencing readiness for advance care planning among people with dementia, family caregivers, and healthcare professionals. +1 more finding

  11. 2026-02-09

    Factors influencing readiness for advance care planning in dementia: a qualitative interview study

    ✓ Peer-reviewed End-of-life care BMC Palliative Care

    Key finding: For people with dementia (n = 6), readiness was facilitated by a desire for autonomy. +4 more findings

  12. 2026-02-09

    Distinct regional patterns of synaptic vulnerability across hippocampal and parahippocampal subregions in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Brain Pathology

    Key finding: We found selective synaptic loss in the entorhinal cortex (-14%, p = 0.017) and parahippocampal gyrus (-14%, p = 0.021) in AD versus controls. +4 more findings

  13. 2026-02-09

    The yes-no reversal phenomenon: Prevalence and correlates in mild cognitive impairment and dementia due to neurodegenerative, chronic cerebrovascular, and mixed etiologies

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer s Disease

    Key finding: YNR+ and YNR- patients were compared on demographics (i.e., age, sex, education), disease duration (in months), disease severity (i.e., MCI versus dementia), etiology and total and subscale-/item-level Mini-Mental State Examination (MMSE) scores. +2 more findings

  14. 2026-02-09

    Measurement differences in the Harmonized Cognitive Assessment Protocol across ethnicity and language in the United States

    ✓ Peer-reviewed Getting a diagnosis Neuropsychology

    Key finding: We observed measurement differences in the HCAP across H/L and NHW older adults for the memory, language, executive functioning, and orientation, but not visuospatial, domains. +4 more findings

  15. 2026-02-09

    Recombinant zoster vaccine is associated with a reduced risk of dementia

    ✓ Peer-reviewed Prevention and risk Nature Communications

    Key finding: Vaccines to prevent herpes zoster have been associated with reduced dementia risk. +4 more findings

  16. 2026-02-08

    Blood-based biomarkers for Alzheimer's disease: Advances in early detection and monitoring of age-related neurodegeneration

    ✓ Peer-reviewed Biomarkers Ageing research reviews

    Key finding: These minimally invasive biomarkers demonstrate exceptional diagnostic accuracy with p-tau217 achieving AUC values greater 0.93 and 91 % positive predictive value in detecting AD pathology, Critically, these biomarkers can identify pathological changes 15-20 years before symptom onset, with plasma p-tau217 levels increasing over 8.5 % annually during preclinical stages. +4 more findings

  17. 2026-02-07

    Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort

    ✓ Peer-reviewed Biomarkers The journal of prevention of Alzheimer's disease

    Key finding: Plasma p-tau217 levels measured using Lumipulse and Simoa assays were highly correlated (p < 0.001). +4 more findings

  18. 2026-02-07

    Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized controlled trial

    ✓ Peer-reviewed Genetics Brain : a journal of neurology

    Key finding: A meta-analysis of two multidomain lifestyle intervention trials found greater cognitive benefits in APOE4 carriers compared with non-carriers. +3 more findings

  19. 2026-02-06

    Beyond Glycemic Control: GLP-1RA–Based Therapies and Emerging Targets Beyond the Metabolic Axis

    ✓ Peer-reviewed Drug development Journal of clinical medicine

    Key finding: Considering the overall sci-entific evidence presented, it is important to note that GLPs are no longer just antihyperglycemic drugs but are remarkably versatile, with a future in almost every field of medicine. +3 more findings

  20. 2026-02-06

    Associations between low-dose drinking water lithium exposure and Dementia: A nationwide U.S. ecological study

    ✓ Peer-reviewed Risk factors Environmental pollution (Barking, Essex : 1987)

    Key finding: Compared with counties with low lithium concentrations, those with high concentrations had lower dementia prevalence (prevalence ratio [PR] = 0.965, 95% CI: 0.950, 0.981) and incidence (incidence rate ratio [IRR] = 0.958, 95% CI: 0.939, 0.978), exhibiting non-linear dose-response patterns. +1 more finding

  21. 2026-02-06

    Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms

    ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The article also explores newer monoclonal antibodies—donanemab, gantenerumab, solanezumab, bapineuzumab, crenezumab, and semorinemab—and evaluates nutritional supplements like vitamin E (alpha-tocopherol) and caprylidene. +4 more findings

  22. 2026-02-06

    Comprehensive Review on Alzheimer Disease: Causes, Risk Factors, Pathology, Mechanisms

    ✓ Peer-reviewed Treatments Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The article also explores newer monoclonal antibodies—donanemab, gantenerumab, solanezumab, bapineuzumab, crenezumab, and semorinemab—and evaluates nutritional supplements like vitamin E (alpha-tocopherol) and caprylidene. +4 more findings

  23. 2026-02-06

    Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort

    ✓ Peer-reviewed Genetics Carolina Digital Repository (University of North Carolina at Chapel Hill)

    Key finding: Compared with men, women had greater amyloid burden (B = 0.05; 95% CI, 0.02-0.07; P < .001), Braak stages III and IV (B = 0.05; 95% CI, 0.02-0.08; P = .003) and Braak stages V and VI (B = 0.09; 95% CI, 0.06-0.12; P < .001) tau burden, and AD signature thickness (B = 0.04; 95% CI, 0.02-0.05; P < .001). +4 more findings

  24. 2026-02-06

    Causality between noise pollution and Alzheimer disease: A Mendelian randomization analysis

    ✓ Peer-reviewed Genetics Medicine

    Key finding: The role of noise pollution as a risk factor for Alzheimer disease (AD) is unclear, with observational studies yielding conflicting results susceptible to confounding and reverse causality. +2 more findings

  25. 2026-02-06

    Biomarcadores para diagnóstico e prognóstico de Alzheimer

    ✓ Peer-reviewed Biomarkers Revista Brasileira Militar de Ciências

    Key finding: Trata-se de uma revisão integrativa da literatura com base no modelo PRISMA, com seleção de estudos nas bases de dados Portal de Periódicos da PubMed/Medline, Scielo e Biblioteca Virtual em Saúde, empregando os descritores: Alzheimer, biomarcadores, probióticos, em português e inglês, no período de 2019 a 2024. +4 more findings

Browse the library by subject, with the full score breakdown →